Current Report Filing (8-k)
October 30 2020 - 04:13PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C.
20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13
or 15(d) of the
Securities Exchange
Act of 1934
Date of Report (Date
of earliest event reported): October 27, 2020
HealthLynked
Corp.
(Exact name of registrant
as specified in charter)
Nevada
|
|
000-55768
|
|
47-1634127
|
(State or other jurisdiction
of incorporation)
|
|
(Commission File Number)
|
|
(IRS Employer
Identification No.)
|
|
1035
Collier Center Way Suite 3
Naples,
FL 34110
|
|
|
(Address of principal executive offices)
|
|
(800) 928-7144
(Registrant’s
telephone number, including area code)
N/A
(Former Name or Former Address, if Changed Since
Last Report)
Check the appropriate box below if the
Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions
(see General Instruction A.2. below):
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b)
of the Act: None.
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2
of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by
check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial
accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 5.02
|
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements
of Certain Officers.
|
On October 27, 2020, the
Board of Directors (the “Board”) of HealthLynked Corp., a Nevada corporation (the “Company”),
appointed Heather Monahan as a director of the Company, effective immediately.
Ms. Monahan will receive
an annual grant of $20,000 in shares of restricted stock per annum, vesting in equal amounts on a quarterly basis over each year
of service, as compensation. Other than the foregoing, there are no actual or proposed transactions between Ms. Monahan or any
of her related persons and the Company that would require disclosure under Item 404(a) of Regulation S-K in connection with her
appointment as a director.
Ms. Monahan does not have
any family relationship with any director, executive officer, or person nominated or chosen to become a director or executive officer
of the Company.
On October 29, 2020, the
Company issued a press release announcing the appointment of Ms. Monahan described in Item 5.02 hereto. A copy of the press release
is furnished as Exhibit 99.1 to this Current Report on Form 8-K.
Item 9.01
|
Financial Statements and Exhibits.
|
(d) Exhibits
-1-
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the Registrant has duly caused this Current Report on Form 8-K to be signed on its behalf
by the undersigned hereunto duly authorized.
|
HEALTHLYNKED CORP.
|
|
|
Date: October 30, 2020
|
/s/ George O’Leary
|
|
George O’Leary
|
|
Chief Financial Officer
|
-2-
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Feb 2024 to Mar 2024
HealthLynked (QB) (USOTC:HLYK)
Historical Stock Chart
From Mar 2023 to Mar 2024